SEC Form 4 · accession 0001553878-15-000017
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis A Ausiello
Director
Period of report
Apr 21, 2015
Accepted (ET)
Apr 23, 2015 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 21, 2015 | S | 8,165 | $130.02 | D | 0 | D | |
| Common StockF2 | holding | — | — | — | 3,500 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2014.
- F2The shares of ALNY common stock are held in a trust, of which the reporting person's spouse is the trustee.